8:30 am
Registration & Networking
Navigating an Evolving Regulatory Landscape and Advancing a Global ESG Strategy
9:30 am Chair’s Opening Remarks
9:40 am Discover: Advance Your ESG Function and Future Proofing Your Biopharma Organization Amidst Evolving Global Regulations With a Focus on Double Materiality and Streamlining CSRD Compliance
Synopsis
- How to set up the appropriate infrastructure, processes and governance to ensure compliance to evolving regulations
- How to streamline compliance to CSRD and tackling double materiality
- Hear from one of the most well informed ESG reporting experts at Bayer – a company well known for having one of the most advanced ESG functions – on how tackle the CSRD (ESRS) and SEC and other evolving global regulations impacting life sciences organizations
10:00 am Discover: Adapting a Global Mindset: Navigating the ESG Regulatory Landscape and Your Company’s Growth
Synopsis
- Tackling CSRD readiness and the value of double materiality
- The process enhancements required to improve the quality and integrity of ESG reporting
- Uncover how Regeneron is advancing their global ESG agenda while ensuring they have regulatory readiness as they expand into new markets
10:20 am Discover: Moving Beyond Compliance: Clearing Regulatory Hurdles as a Path to Building Value
Synopsis
- Where to begin and where to go next: Practical steps when it comes to meeting CSRD, ISSB and SEC regulations
- Meeting the scale of the challenge: The role of the Center of Excellence (CoE)
- Beyond spreadsheets: Meeting the data challenge
10:50 am Develop: What more can we learn from forward-thinking ESG leaders on how to successfully navigate an evolving regulatory landscape?
11:10 am Action: What steps will you now take to successfully navigate today’s evolving regulatory landscape?
11:30 am Spotlight: Demystifying Microgrids: the Power of Renewable Energy Beyond Sustainability Goals
Synopsis
- As the demand for power increases among C&I customers, our already overburdened central grid is being driven to the point of failure and industries are rapidly turning to alternative energy sources that can ensure their continuity and collective success, while simultaneously providing a solution to the climate crisis
- Learn how microgrids bring cleaner, cheaper, and more reliable power to communities and industries through real world success stories
- This session will explore the multi-faceted benefits that clean-energy microgrids provide the life sciences industry beyond simply helping achieve sustainability goals and emissions reduction targets and uncover how they provide businesses an economic hedge against constantly increasing electricity rates allowing for better long-term planning.
11:30 am Speed Networking Break
Uncover Future ESG Trends and How to Tackle ESG Change Management in Life Sciences Organizations in 2024
12:20 pm Panel Discussion: The Future of ESG for Life Sciences and ESG Change Management
Synopsis
Questions will include:
- What is the role of different stakeholders – internal and external – and how they are driving demand for ESG and the trends surrounding this? What are the tactics to get buy in from each of these?
- How do we focus on what matters to our stakeholders in light of the evolving regulatory landscape including the upcoming SEC regulations?
- Given the changing expectations for ESG from customers, do we need different skill sets to address these in the ESG function?
- How will the different aspects of ESG – sustainability, access to medicines etc – come together to form an integrated ESG strategy?
- What do ESG functions for life sciences organizations look like now and what will they look like in 5 years? What is the evolving role of finance, legal and compliance in ESG in different stage and size life sciences organizations? How do we navigate the change management processes involved in cross functional collaboration?
1:00 pm Action: What will you now do to get ahead of future ESG trends and prepare for change?
1:20 pm Lunch
Demonstrating Sustainable Value Creation to Make a Business Case for ESG
2:20 pm Discover: Next Steps: How to Effectively Advance Your ESG Function
Synopsis
- Building an ESG program from scratch and establish a governance function
- Creating short-term KPIs using a materiality assessment and tackling product circularity
- How Natera built an entire ESG function in a very short amount of time and are now taking the next steps to advance the function even further
3:00 pm Discover: Agile Approaches to Securing the Business Buy in for an ESG Function and How to Quickly Adapt to a Changing Regulatory Landscape
Synopsis
- When operating with limited budgets and resources how do you inspire colleagues to get involved in achieving ESG goals and leverage cross-functional relationships and budgets to build an ESG program at high speed
- Engaging employees in developing a climate strategy in alignment with the recommendations of TCFD
- How BeiGene is building long-term value and working towards a sustainable ROI from ESG in today’s evolving regulatory landscape
3:20 pm Develop: What other questions do you have for experts who have been successful in making a business case for ESG and driving sustainable value creation?
3:20 pm Discover: Building an Integrated ESG and Business Strategy for Pharmaceutical Companies
Synopsis
- How to systematically embed sustainability in the business and building a governance for this strategy which is rock solid and trust able for investment
- Considering not how to not only meet regulatory requirement but rather reviewing your impact and how to subsequently embed this in a business model
- How Bayer has implemented a three-step process to ensure sustainability is institutionalized in the company and turned sustainability strategy into an investable framework
3:40 pm Action: How will you now rethink your strategy to make a business case for ESG and driving sustainable value creation?
4:00 pm
Networking Break
Navigating How to Successfully Execute Towards Your (Science-Based) Targets and Commitments
4:20 pm Discover: The Carbon Impact of Biotech and Pharma: Achieving the UN Race to Zero Across the Value Chain
Synopsis
- Biotech and Pharma industries progress on decarbonization and Race to Zero outcomes
- Programs and collective actions that are catalyzing industry-wide transformation
- The critical roles of Lab and Lab Supply Chains in a Net Zero Future for life science
4:50 pm Discover: Unconventional and Successful New Approaches to Reduce Electricity and Fossil Fuel Usage and Drive Towards Your Net Zero Decarbonzation Target
Synopsis
- Innovation in governing scope 1 vs scope 2 reductions
- Practical steps to by-pass uncertainty and deliver business buy-in
- How Themo Fisher Scientific takes a new approach to successfully drive towards its net zero commitment by tackling fossil fuels and electricity